SurModics
SRDX
$33.93
Share price
32.07%
Change (1 day)
47.59%
Change (1 year)
Categories
SurModics (SRDX) - P/B ratio
P/B ratio as of May 2024 : 2.99
According to SurModics's latest financial reports the company has a price-to-book ratio of 2.99.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
SurModics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.24 | -5.74% |
| 2022-12-31 | 4.49 | -8.74% |
| 2021-12-31 | 4.92 | 10.31% |
| 2020-12-31 | 4.46 | -2.26% |
| 2019-12-31 | 4.57 | -18.57% |
| 2018-12-31 | 5.61 | 67.78% |
| 2017-12-31 | 3.34 | 6.32% |
| 2016-12-31 | 3.14 | 13.69% |
| 2015-12-31 | 2.76 | -21.04% |
| 2014-12-31 | 3.50 | -6.25% |
| 2013-12-31 | 3.74 | 12.46% |
| 2012-12-31 | 3.32 | 84.78% |
| 2011-12-31 | 1.80 | 34.02% |
| 2010-12-31 | 1.34 | -40.65% |
| 2009-12-31 | 2.26 | -20.18% |
| 2008-12-31 | 2.83 | -60.81% |
| 2007-12-31 | 7.23 | 74.61% |
| 2006-12-31 | 4.14 | -25.58% |
| 2005-12-31 | 5.56 | -2.54% |
| 2004-12-31 | 5.71 | 24.15% |
| 2003-12-31 | 4.60 | -33.15% |
| 2002-12-31 | 6.88 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.07 | 69.21% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.74 | 58.17% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 4.63 | 54.79% | 🇺🇸 USA |
 Agilent Technologies A | 6.49 | 116.76% | 🇺🇸 USA |
 PerkinElmer
PKI | 1.80 | -39.90% | 🇺🇸 USA |
 Alkermes ALKS | 3.45 | 15.30% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | 2.05 | -31.64% | 🇺🇸 USA |
 Heron Therapeutics HRTX | -10.3 | -442.88% | 🇺🇸 USA |
 Enzo Biochem ENZ | 0.7527 | -74.86% | 🇺🇸 USA |